Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib

Published:2019-11-07 Issue:23-24 Volume:103 Page:9569-9582
ISSN:0175-7598
Container-title:Applied Microbiology and Biotechnology
language:en
Short-container-title:Appl Microbiol Biotechnol

Author:

Dong Yan,Lin Yao,Gao Xiaotong,Zhao Yingxin,Wan Zhuo,Wang Haotian,Wei Mengying,Chen Xutao,Qin Weiwei,Yang Guodong,Liu Li

Funder

National Natural Science Foundation of China

Shaanxi Provincial Science and Technology Department

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s00253-019-10127-3.pdf

Reference48 articles.

1. Aizawa S, Fujiwara Y, Contu VR, Hase K, Takahashi M, Kikuchi H, Kabuta C, Wada K, Kabuta T (2016) Lysosomal putative RNA transporter SIDT2 mediates direct uptake of RNA by lysosomes. Autophagy 12(3):565–578. https://doi.org/10.1080/15548627.2016.1145325

2. Apperley JF (2015) Chronic myeloid leukaemia. Lancet 385(9976):1447–1459. https://doi.org/10.1016/s0140-6736(13)62120-0

3. Azam M, Latek RR, Daley GQ (2003) Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112(6):831–843

4. Berman E, Jhanwar S, Hedvat C, Arcila ME, Wahab OA, Levine R, Maloy M, Ma W, Albitar M (2016) Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). Leuk Res 49:108–112. https://doi.org/10.1016/j.leukres.2016.08.006

5. Bixby D, Talpaz M (2011) Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 25(1):7–22. https://doi.org/10.1038/leu.2010.238

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules;Frontiers in Oncology;2024-01-08

2. Elimination of Reactive Oxygen Species Formed by Chemotherapeutic Agent in Imatinib Resistant K562r Cell Line by Sweetgum Oil;GAZI MED J;2024

3. Progress on the pathological tissue microenvironment barrier-modulated nanomedicine;Advanced Drug Delivery Reviews;2023-09

4. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways;Annals of Hematology;2023-08-01

5. Tumour‑derived exosomes and their emerging roles in leukaemia (Review);Experimental and Therapeutic Medicine;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3